Prevalence of Class I Integron Gene in Carbapenem-Resistant Enterobacteriaceae Strains Isolated from Hospitalized Patients

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 130

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEM-10-4_004

تاریخ نمایه سازی: 21 آذر 1403

چکیده مقاله:

Background: The prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is a growing global public health concern due to the significant morbidity and mortality associated with infections caused by these bacteria. The main objective of this study was to determine the prevalence of class I integron in CRE isolates collected from patients in teaching hospitals affiliated to Mazandaran University of Medical Sciences (MAZUMS). Materials & Methods: A total of ۱۰۰ Enterobacteriaceae isolates were collected during March ۲۰۲۲ to March ۲۰۲۳ from MAZUMS teaching hospitals using a consecutive sampling technique. The isolates were distinguished using standard microbiological methods. The antibiotic resistance of the isolated strains to carbapenem was subsequently detected using antibiotic discs including imipenem and meropenem. Using the disc diffusion method, ۷۳ carbapenem-resistant isolates were identified and subsequently investigated by genetic analysis using polymerase chain reaction (PCR). Findings: Among the ۷۳ carbapenem-resistant isolates, the most commonly found bacterial isolates were Klebsiella pneumoniae (۳۹.۷۲%), Escherichia coli (۳۰.۱۳%), and Serratia rubidaea (۱۲.۳۲%), respectively. Also, ۱۰۰% of the isolates were resistant to meropenem, while these isolates showed lower resistance to imipenem (۷۰%). Also, out of the ۷۳ isolates, ۶۴.۳۸% were positive for the intI۱ gene. K. pneumoniae isolates had the highest prevalence of the intI۱ gene (۸۹.۶۵%). Conclusion: The prevalence of class I integron among patients in MAZUMS educational hospitals is relatively high, exceeding ۵۰%. Therefore, it is crucial to implement effective infection prevention measures and identify this gene in hospitals to hinder the rapid dissemination of these hazardous organisms.

نویسندگان

Mehrdad Gholami

Department of Medical Microbiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Shadi Aghamohammad

Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran

Soheil Asghari

Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Maryam Salehian

Department of Medical Microbiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Alireza Davodi Badabi

Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Mohammad Ahanjan

Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • (۱) Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: ...
  • (۲) Suay-García B, Pérez-Gracia MT. Present and future of carbapenem-resistant ...
  • (۳) Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging ...
  • (۴) Livorsi DJ, Chorazy ML, Schweizer ML, Balkenende EC, Blevins ...
  • (۵) Codjoe FS, Donkor ES. Carbapenem resistance: A review. Med ...
  • (۶) Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-resistant ...
  • (۷) Banerjee R, Humphries R. Clinical and laboratory considerations for ...
  • (۸) Shahbazi S, Karam MR, Habibi M, Talebi A, Bouzari ...
  • (۹) Shivaee A, Shahbazi S, Soltani A, Ahadi E. Evaluation ...
  • (۱۰) Zheng W, Huyan J, Tian Z, Zhang Y, Wen ...
  • (۱۱) Akrami F, Rajabnia M, Pournajaf A. Resistance integrons: A ...
  • (۱۲) Esmaeelzadeh Dizaji R, Jahantigh M, Rashki A. The molecular ...
  • (۱۳) Ghaly TM, Tetu SG, Gillings MR. Predicting the taxonomic ...
  • (۱۴) Alikhani MY, Parsavash S, Arabestani MR, Hosseini SM. Prevalence ...
  • (۱۵) Urban-Chmiel R, Marek A, Stępień-Pyśniak D, Wieczorek K, Dec ...
  • (۱۶) Wang T, Zhu Y, Zhu W, Cao M, Wei ...
  • (۱۷) Shahkolahi S, Shakibnia P, Shahbazi S, Sabzi S, Badmasti ...
  • (۱۸) Taati Moghadam M, Hossieni Nave H, Mohebi S, Norouzi ...
  • (۱۹) Goldstein C, Lee MD, Sanchez S, Hudson C, Phillips ...
  • (۲۰) Kim SH, Kim GR, Jeong J, Kim S, Shin ...
  • (۲۱) Yan J, Pu S, Jia X, Xu X, Yang ...
  • (۲۲) Liu M, Liu J, Ma J, Li W, Zhao ...
  • (۲۳) Kargar M, Mohammadalipour Z, Doosti A, Lorzadeh S, Moein ...
  • (۲۴) Wang H, Yan Z, Mu L, Gao XY, Li ...
  • (۲۵) Jabalameli L, Rahmatpanah M, Gomar H, Ashkarmeidani MS, Pabandi ...
  • نمایش کامل مراجع